Bull of the Day: Hinge Health, Inc. (HNGE)

HNGE carries a Zacks Rank #1 (Strong Buy) after a Q3 earnings beat and raised guidance, putting the virtual physical-therapy name on momentum screens.

The numbers behind the upgrade: revenue grew 52% YoY, and corporate clients rose 28% YoY. The company, which also offers migraine treatment and gastrointestinal care, is projected to double revenue between 2025 and 2027.

The stock has done the heavy lifting already. HNGE shares are up 160% YTD since the May 2025 IPO. Part of that run reflects the broader rotation out of AI stocks into healthcare, according to the source, which means HNGE is trading on both company-specific execution and a sector flow.

Interpretation: a 160% gain in roughly one trading year means expectations are elevated. The raised guidance and a top-tier Zacks Rank supply fundamental support, but a doubling-revenue projection leaves little margin for a growth stumble. Because part of the rally is tied to the AI-to-healthcare rotation, a reversal in that flow could pressure the shares independent of earnings.